Related Experiment Video
Updated: Jul 16, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
Inactivation of the candidate tumor suppressor par-4 in endometrial cancer
Gema Moreno-Bueno1, Pablo J Fernandez-Marcos, Manuel Collado
1Breast and Gynecological Cancer Group, Tumor Suppression Group, Spanish National Cancer Center (CNIO), 3 Melchior Fernandez Almagro Street, Madrid E-28029, Spain.
Abstract:
Recently, it has been shown that mice deficient in the proapoptotic protein prostate apoptosis response 4 (Par-4) are specifically prone to develop endometrial carcinomas. Based on this, we have examined here the possible role of Par-4 as a tumor suppressor gene in human endometrial cancer. Using cDNA arrays, quantitative reverse transcription-PCR, and immunohistochemistry, we detected Par-4 down-regulation in approximately 40% of endometrial carcinomas. This alteration was not associated with phosphatase and tensin homologue (PTEN), K-RAS, or beta-catenin mutations, but was more frequent among tumors showing microsatellite instability (MSI) or among tumors that were estrogen receptor positive. Mutational analysis of the complete coding sequence of Par-4 in endometrial cancer cell lines (n = 6) and carcinomas (n = 69) detected a mutation in a single carcinoma, which was localized in exon 3 [Arg (CGA) 189 (TGA) Stop]. Interestingly, Par-4 promoter hypermethylation was detected in 32% of the tumors in association with low levels of Par-4 protein and was more common in MSI-positive carcinomas. Par-4 promoter hypermethylation and silencing was also detected in endometrial cancer cell lines SKUT1B and AN3CA, and reexpression was achieved by treatment with the demethylating agent 5'-aza-2'-deoxycytidine. Together, these data show that Par-4 is a relevant tumor suppressor gene in human endometrial carcinogenesis.
Insights
Prostate apoptosis response 4 (Par-4) acts as a tumor suppressor in human endometrial cancer. Down-regulation and promoter hypermethylation of Par-4 were observed in many endometrial tumors, suggesting its crucial role in preventing cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate apoptosis response 4 (Par-4) is a proapoptotic protein.
- Par-4 deficient mice exhibit increased susceptibility to endometrial carcinomas.
- The role of Par-4 in human endometrial cancer remains to be elucidated.
Purpose of the Study:
- To investigate the potential of Par-4 as a tumor suppressor gene in human endometrial cancer.
- To determine the frequency and mechanisms of Par-4 alterations in endometrial carcinomas.
Main Methods:
- Quantitative reverse transcription-PCR and cDNA arrays were used to assess Par-4 expression levels.
- Immunohistochemistry was employed to evaluate Par-4 protein status.
- Mutational analysis and promoter methylation studies were conducted on tumor samples and cell lines.
Main Results:
- Par-4 down-regulation was detected in approximately 40% of human endometrial carcinomas.
- Par-4 alterations were more frequent in estrogen receptor-positive tumors and those with microsatellite instability (MSI).
- Par-4 promoter hypermethylation was identified in 32% of tumors, leading to gene silencing, and was reversible with demethylating agents.
Conclusions:
- Par-4 functions as a significant tumor suppressor gene in human endometrial carcinogenesis.
- Down-regulation of Par-4, primarily through promoter hypermethylation, contributes to endometrial tumor development.
- Restoring Par-4 expression offers a potential therapeutic strategy for endometrial cancer.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of Cdk Activity
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
